BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 26483206)

  • 21. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer.
    Zhi X; Tao J; Xie K; Zhu Y; Li Z; Tang J; Wang W; Xu H; Zhang J; Xu Z
    Cancer Lett; 2014 Apr; 346(1):104-13. PubMed ID: 24374017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway.
    Xu W; Wang Z; Zhang W; Qian K; Li H; Kong D; Li Y; Tang Y
    Cancer Lett; 2015 Jan; 356(2 Pt B):613-27. PubMed ID: 25305448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
    Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
    Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
    Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
    Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FOXM1 and its oncogenic signaling in pancreatic cancer pathogenesis.
    Huang C; Du J; Xie K
    Biochim Biophys Acta; 2014 Apr; 1845(2):104-16. PubMed ID: 24418574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZNF281 Promotes Growth and Invasion of Pancreatic Cancer Cells by Activating Wnt/β-Catenin Signaling.
    Qian Y; Li J; Xia S
    Dig Dis Sci; 2017 Aug; 62(8):2011-2020. PubMed ID: 28523575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
    Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
    Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation.
    Chen Y; Li Y; Xue J; Gong A; Yu G; Zhou A; Lin K; Zhang S; Zhang N; Gottardi CJ; Huang S
    EMBO J; 2016 Mar; 35(6):668-84. PubMed ID: 26912724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Merlin is a negative regulator of human melanoma growth.
    Murray LB; Lau YK; Yu Q
    PLoS One; 2012; 7(8):e43295. PubMed ID: 22912849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
    Sun H; Gao Y; Lu K; Zhao G; Li X; Li Z; Chang H
    World J Surg Oncol; 2015 Oct; 13():307. PubMed ID: 26499380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
    Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
    Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling.
    Thu KL; Radulovich N; Becker-Santos DD; Pikor LA; Pusic A; Lockwood WW; Lam WL; Tsao MS
    Oncogene; 2014 Jan; 33(3):279-88. PubMed ID: 23318427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of FoxM1 promotes differentiation of bone marrow mesenchymal stem cells into alveolar type II cells through activating Wnt/β-catenin signalling.
    Zeng M; Chen Q; Ge S; He W; Zhang L; Yi H; Lin S
    Biochem Biophys Res Commun; 2020 Jul; 528(2):311-317. PubMed ID: 32475644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
    Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
    Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.
    Motiwala T; Kutay H; Zanesi N; Frissora FW; Mo X; Muthusamy N; Jacob ST
    Leukemia; 2015 Jun; 29(6):1350-9. PubMed ID: 25482129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Foxm1 mediates cross talk between Kras/mitogen-activated protein kinase and canonical Wnt pathways during development of respiratory epithelium.
    Wang IC; Snyder J; Zhang Y; Lander J; Nakafuku Y; Lin J; Chen G; Kalin TV; Whitsett JA; Kalinichenko VV
    Mol Cell Biol; 2012 Oct; 32(19):3838-50. PubMed ID: 22826436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61.
    Sano M; Driscoll DR; DeJesus-Monge WE; Quattrochi B; Appleman VA; Ou J; Zhu LJ; Yoshida N; Yamazaki S; Takayama T; Sugitani M; Nemoto N; Klimstra DS; Lewis BC
    Neoplasia; 2016 Dec; 18(12):785-794. PubMed ID: 27889647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.